|Articles|January 1, 2018
- Pharmaceutical Executive-01-01-2018
- Volume 38
- Issue 1
Pharmaceutical Executive, January 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Changing Skies: Pharm Exec’s 2018 Industry Forecastalmost 8 years ago
Q&A: From Gleevec to CAR-Talmost 8 years ago
Prices and Competition to Shape the Year Aheadalmost 8 years ago
CAR-T Concerns for Continued Successalmost 8 years ago
New Year, Next Steps in Digital Transformationalmost 8 years ago
Food for Thought in Cancer Fightalmost 8 years ago
Parting Arrangementsalmost 8 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
5
